Tag Archives: HL

Computers

Review: Brother's HL-3170CDW color laser-class printer is inexpensive, but graphics are mediocre

Leave a comment

You want a color laser printer, but you don’t have a lot of cash. How does $280 sound? That’s the price of the Brother HL-3170CDW, and in exchange it delivers reasonably good prints. Not pristine, evocative color graphics—move on to another printer for that. But good text and decent spot color, it can do, and the toner costs are tolerable as well.

Here’s the real decision: Do you pick this all-around-average machine, or do you pick this other, like-priced color laser, the Dell C1760nw, which has much better color quality—but also much more expensive toner? Or do you think a bit outside of the box and consider a business inkjet, such as the Epson WorkForce WP-4020, which competes head-to-head with both of these lasers on speed, print quality, and features, and whomps them both on cost of consumables? By our reckoning the latter is the best deal, but some people just can’t get laser out of their heads, and they will have to think harder about the tradeoffs.

Bulky profile, basic features, and duplexing

Measuring 16.1 inches wide by 18.3 inches deep by 9.4 inches wide and weighing 39 pounds, the HL-3170CDW is fairly large and beefy for an entry-level, laser-class printer (it uses LED technology to produce basically identical results). The height is due more to the stacked toner/drum system than the bottom-mounted, 250-sheet paper cassette. There’s also a 100-sheet output tray integrated into the top of the unit, and a single-sheet manual feed for envelopes and glossy photo paper. The unit prints automatically in duplex.

When some color printers run low on one color, they will complain, but keep printing. Not so with the HL-3170CDW: It will not print when you run out of any of the four colors. This can be a problem if you really, really need to print something and haven’t any spare toner. Better a warning and a less-than-optimal printout, than no printout at all. Brother needs to rethink this.

To read this article in full or to leave a comment, please click here

…read more

Source: FULL ARTICLE at PCWorld

Business, Finance, Occupation & Industry

Kulicke & Soffa Extends Power Series to Wedge Bond with PowerFusionPS

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Kulicke & Soffa Extends Power Series to Wedge Bond with PowerFusion PS

SINGAPORE–(BUSINESS WIRE)– Kulicke & Soffa Industries, Inc. (NAS: KLIC) (“K&S” or the “Company”) today announced another extension of its highly successful K&S Power SeriesTM equipment. The Company’s new high performance Orthodyne wedge bonder, PowerFusionPS, is driven by a new powerful direct-drive motion system and expanded pattern recognition capabilities which deliver industry leading productivity and performance.

The PowerFusionPS fits well into the Power Series of products, known for setting new standards for productivity, performance, advanced package capability, ease of use, configuration flexibility and reliability. PowerFusionPS boasts increased UPH that is enabled by the direct-drive servo system and faster pattern recognition find times. It also shows higher MTBA due to the improved pattern recognition. The advanced package capabilities of PowerFusionPS improves the processing of high-density power packages, due to an expanded bondable area, wider leadframe capability and superior indexing accuracy and teach mode.

PowerFusion PS is available in two different models with single or multiple head configurations. The TL Model is the perfect choice for bonding single-row to four-row matrix TO- power discrete packages. The enhanced HL model is intended for advanced power package designs. When bonding high density power devices, like SO-8 & PDFN, or stretching the wire limits on a matrix D-Pak, the superior indexing accuracy and clamping capabilities of the HL Model deliver consistent performance.Both Models provide industry leading productivity that lowers cost of ownership by improved uptimes and higher bond yields.

Matt Vorona, Kulicke & Soffa’s Vice President – Wedge Bond Business Unit, remarked, “Our state of the art PowerFusionPS series by K&S launches a product firmly in the tradition of Orthodyne wedge bonders, well known in the power semiconductor industry for leading edge innovation, productivity and performance.”

Customers can view the highly anticipated wedge bonder during the SEMICON China show from March 19-21, 2013 in the Kulicke & Soffa Booth #3401.

About Kulicke & Soffa

Kulicke & Soffa (NAS: KLIC) is a global leader in the design and manufacture of semiconductor and LED assembly equipment. As a pioneer in this industry, K&S has provided customers with market leading packaging solutions for decades. In recent years, K&S has expanded its product offerings through strategic acquisitions, adding wedge bonding and a broader range of expendable tools to its core ball bonding products. Combined with …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Seattle Genetics Submits Supplemental BLA to FDA for Retreatment and Extended Duration of Therapy wi

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Seattle Genetics Submits Supplemental BLA to FDA for Retreatment and Extended Duration of Therapy with ADCETRIS ® (Brentuximab Vedotin) in Relapsed Hodgkin Lymphoma and Systemic ALCL

BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (NAS: SGEN) announced today that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) supporting the use of ADCETRIS (brentuximab vedotin) for retreatment and extended duration beyond 16 cycles of therapy in relapsed Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (sALCL). ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30, a defining marker of HL and sALCL, that was granted accelerated approval by the FDA in August 2011 for relapsed HL and relapsed sALCL.

“The sBLA submission includes data demonstrating ADCETRIS activity in managing HL and sALCL when used in the retreatment setting, as well as beyond the 16 cycles described in our current label, while retaining a manageable safety profile,” said Clay B. Siegall, Ph.D., President and Chief Executive Officer of Seattle Genetics. “Our goal is to broaden the ADCETRIS U.S. labeling claims to provide both patients and physicians the opportunity to incorporate ADCETRIS into additional HL and sALCL treatment settings. The sBLA submission includes data that support these uses and we look forward to the regulatory outcome.”

The sBLA is based on results from a phase II clinical trial with two treatment arms. One arm evaluated retreatment with ADCETRIS in patients who previously responded to treatment with ADCETRIS, then discontinued treatment and subsequently had disease progression or relapse. The other arm allowed treatment extension and evaluated prolonged treatment with ADCETRIS beyond 16 cycles of therapy. The sBLA submission includes updated data sets from this phase II trial. Preliminary data from this trial were previously reported at the 2011 American Society of Hematology (ASH) Annual Meeting and at the 2012 American Society of Clinical Oncology (ASCO) Annual meeting.

At the 2012 ASCO Annual Meeting, retreatment data from the phase II trial were reported from 23 patients, including one patient who was treated twice. Patients had received a median of four prior systemic therapies, including ADCETRIS. Of 23 evaluable patients, 70 percent (16 of 23) achieved an objective response after retreatment with ADCETRIS, including nine complete remissions and seven partial remissions. Median duration of retreatment objective response was 8.8 months. Among retreated HL patients, nine of 16 (56 percent) achieved an objective response. Among retreated sALCL patients, seven of eight (88 percent) achieved an objective response. The most common adverse events were peripheral neuropathy (46 percent), nausea (42 percent), fatigue (38 percent), diarrhea (33 percent) and fever (29 percent).

…read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

24/7 Wall St. Closing Bell — March 8, 2013: Markets Maintain Buying Trend (TIF, SKUL, TWX, HL, AAPL, FNSR, HRB, P, WDAY, ANN, FL, CSIQ, CHYR, DKS, RENN, P, VALE, VOD)

Leave a comment

By 24/7 Wall St.

Bull and Bear figures

Filed under:

U.S. equity markets opened higher this morning mostly on the strength of a far-better-than-expected report on U.S. non-farm payrolls and a lower-than-expected unemployment rate of 7.7% (more coverage here). In Europe, German industrial production was flat while Spain’s declined a bit less than estimated. The French prime minister said the county needs to save €5 billion in spending this year, and he expects to achieve that through spending cuts. In Asia, Japan’s GDP growth for the fourth quarter was revised to flat with the previous year, again better than expected. The country also posted a small — and unexpected — trade surplus. China’s trade surplus was also larger than expected, likely due to the impact of the lunar new year holiday in February. Fitch downgraded Italy’s sovereign debt shortly after noon, briefly chilling investors (more coverage here).

The U.S. dollar index rose 0.73% today, now at 82.686. The GSCI commodity index is up 0.8% at 646.65, with commodities prices mixed today. WTI crude oil closed up 0.4% today, at $91.95 a barrel, up 1.4% for the week. Brent crude trades down 0.3% at $110.85 a barrel. Natural gas is up 1.3% today at about $3.63 per million BTUs. Gold settled up fractionally today at $1,576.90 an ounce, and up 0.3% for the week.

The unofficial closing bells put the DJIA up about 63 points to 14,392.46 (0.44%), the NASDAQ rose about 12 points (0.38%) to 3,244.35, and the S&P 500 rose 0.42% or more than 6 points to 1,550.77.

There were a several analyst upgrades and downgrades today, including Tiffany & Co. (NYSE: TIF) cut to ‘sell’ at Canaccord Genuity; Skullcandy Inc. (NASDAQ: SKUL) cut to ‘underweight’ at Piper Jaffray and cut to ‘underperform’ at Raymond James and D.A. Davidson; Time Warner Inc. (NYSE: TWX) raised to ‘buy’ with a price target of $68 at Argus; Hecla Mining Co. (NYSE: HL) raised to ‘buy’ at Global Hunter; and Apple Inc. (NASDAQ: AAPL) reiterated as ‘outperform’ with a price target of $600 at Credit Suisse.

Earnings reports since markets closed last night resulted in several price moves today, including these: Finisar Corp. (NASDAQ: FNSR) is down 8.7% at $14.46; H & R Block Inc. (NYSE: HRB) is up 9.2% at $27.27 after posting a new 52-week high of $27.50 earlier today; Pandora Media Inc. (NYSE: P) is up 17.1% at $13.74 after posting a new 52-week high of $14.70 earlier today (more coverage here); Workday Inc. (NASDAQ: WDAY) is up 0.9% at $62.20; Ann Inc. (NYSE: ANN) is up 7.7% at $31.23; and Foot Locker Inc. (NYSE: FL) is down 6.9% at $32.89 (more coverage here).

Before markets open Monday morning we are scheduled to hear from Canadian Solar Inc. (NASDAQ: CSIQ), Chyron Corp. (NASDAQ: CHYR), Dick’s Sporting Goods Inc. (NYSE: DKS), and Renren Inc. (NASDAQ: RENN).

Some standouts among high-volume stocks today include:

Pandora Media Inc. (NYSE: P) is up 17.1% at $13.74. This Internet radio company not only posted results that investors liked, the company’s CEO announced that he is leaving.

Vale SA …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Today's Market Winners and Losers

Leave a comment

By 24/7 Wall St.

images traders

Filed under:

The stock market is down Monday, with the Dow Jones Industrial Average down 0.35%, the Nasdaq down 0.20% and the S&P 500 down 0.20%. Today’s winners include a materials manufacturer getting bought out and an insurer bolstering capital. Today’s losers include a mattress retailer who will likely report weaker-than-expected financials for the first quarter and a mining firm buying out a rival.

These are Monday’s market winners and losers.

Biggest Winners

Shares of Ferro Corp. (NYSE: FOE) are up 29.13% to $6.72 on trading volume of 7.4 million shares. Chemical firm A. Schulman, Inc. (NASDAQ: SHLM) has offered to buy the company for $563 million in cash and stock. Before Monday, the 52-week high was $6.39.

Shares of MGIC Investment Corp. (NYSE: MTG) are up 9.78% to $4.16 on trading volume of 10.1 million shares. The company announced it may bolster capital, indicating to investors that the company may take on more risk involving the housing market. The 52-week high is $5.15.

Biggest Losers

Shares of Select Comfort Corporation (NASDAQ: SCSS) are down 15.16% to $17.40 on trading volume of 2.7 million shares. The mattress retailer said its February sales were below internal targets, and the firm would likely miss its goals for the first quarter. Before Monday, the 52-week low was $19.00.

Shares of Hecla Mining Co. (NYSE: HL) are down 12.07% to $4.08 on trading volume of 3.7 million shares. The mining firm will buy Aurizon Mines Ltd. (AMEX: AZK) for $774 million in order to gain control of a gold mine in Quebec. The 52-week low is $12.07.

Follow Samuel on Twitter: SWeigley 

Filed under: 24/7 Wall St. Wire Tagged: AZK, FOE, HL, MTG, SCSS, SHLM

Read | Permalink | Email this | Linking Blogs | Comments

…read more
Source: FULL ARTICLE at DailyFinance